CODI-M codi-m.com

CODI-M (코디엠) (KOSDAQ: 224060) is a Korean biotech firm that has a pipeline of drug candidates for colorectal cancer, rheumatoid arthritis and inflammation diseases.

CODI-M (코디엠) (KOSDAQ: 224060) is a Korean biotech firm that has a pipeline of drug candidates for colorectal cancer, rheumatoid arthritis and inflammation diseases.

See All Exits Recent Exits

Phone: +82) 2.554.9300

Fax:

Songam Building, 9F
441 Teheran-ro, Gangnam-gu
Seoul,
South Korea

CODI-M - Investments & Acquisitions

Show Real Data CODI-M Investments
See all Recent Investments
Date Company Round Amount Co-investors
2018-04-01PeproMene BioCorporate Minority - II$2M
2016-12-27WellMarker BioSeed$2.48M
See all 2 investments